National Microbiology Laboratory

That was Rachel Glennerster, the president of the Centre for Global Development.

The Ervebo vaccine was initially engineered by scientists of the Public Health Agency of Canada's National Microbiology Laboratory, who have one of the few facilities in the world capable of safely handling the live Ebola virus.

The technology was subsequently licensed to the American biotechnology company NewLink Genetics.

This is the epicenter of the outbreak.